These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7578517)

  • 21. Treatment of chronic pseudomonas aeruginosa infection in cystic fibrosis patients with ceftazidime and tobramycin.
    Heilesen AM; Permin H; Koch C; Høiby N
    Scand J Infect Dis; 1983; 15(3):271-6. PubMed ID: 6417770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The combination of topical ceftazidime and aminoglycosides in the treatment of refractory pseudomonal keratitis.
    Robinson A; Kremer I; Avisar R; Gaton D; Savir H; Yassur Y
    Graefes Arch Clin Exp Ophthalmol; 1999 Mar; 237(3):177-80. PubMed ID: 10090578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Penicillin or vancomycin plus ceftazidime in febrile neutropenic patients after stem cell transplantation.
    Kargar Samani K; Vandercam B; Straetmans N; Michaux L; Ferrant A
    Acta Clin Belg; 2000; 55(5):279-84. PubMed ID: 11109643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Linezolid for the treatment of complicated skin and skin structure infections in children.
    Yogev R; Patterson LE; Kaplan SL; Adler S; Morfin MR; Martin A; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S172-7. PubMed ID: 14520143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidrug-resistant Pseudomonas aeruginosa skin and soft-tissue infection successfully treated with ceftolozane/tazobactam.
    Castaldo N; Givone F; Peghin M; Righi E; Sartor A; Bassetti M
    J Glob Antimicrob Resist; 2017 Jun; 9():100-102. PubMed ID: 28495526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New quinolone versus vancomycin/tobramycin for intestinal sterilization in patients who undergo allogeneic bone marrow transplantation].
    Hosen N; Teshima H; Karasuno T; Ujiie H; Nakao T; Yagi T; Hatanaka K; Kawamoto S; Hiraoka A; Nakamura H; Masaoka T
    Rinsho Ketsueki; 1999 Jan; 40(1):9-15. PubMed ID: 10067090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infection Group.
    Nichols RL; Graham DR; Barriere SL; Rodgers A; Wilson SE; Zervos M; Dunn DL; Kreter B
    J Antimicrob Chemother; 1999 Aug; 44(2):263-73. PubMed ID: 10473234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stability of high-dose vancomycin and ceftazidime in peritoneal dialysis solutions.
    Stamatakis MK; Leader WG; Tracy TS
    Am J Health Syst Pharm; 1999 Feb; 56(3):246-8. PubMed ID: 10030511
    [No Abstract]   [Full Text] [Related]  

  • 29. Bullous haemorrhagic cellulitis caused by Enterobacter cloacae.
    Dyachenko P; Ziv M; Kamil S; Dodiuk-Gad R; Chazan B; Rozenman D
    J Eur Acad Dermatol Venereol; 2005 Nov; 19(6):763-4. PubMed ID: 16268890
    [No Abstract]   [Full Text] [Related]  

  • 30. Linezolid and quinupristin/dalfopristin: novel antibiotics for gram-positive infections of the skin.
    Schweiger ES; Scheinfeld NS; Tischler HR; Weinberg JM
    J Drugs Dermatol; 2003 Aug; 2(4):378-83. PubMed ID: 12884459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergy of new C-3 substituted cephalosporins and tobramycin against Pseudomonas aeruginosa and Pseudomonas cepacia.
    Chin NX; Neu HC
    Diagn Microbiol Infect Dis; 1989; 12(4):343-9. PubMed ID: 2512049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis.
    Smith AL; Fiel SB; Mayer-Hamblett N; Ramsey B; Burns JL
    Chest; 2003 May; 123(5):1495-502. PubMed ID: 12740266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pseudomonas aeruginosa: its complications in the lower extremity. Case presentations and discussion.
    Feder JA
    J Am Podiatry Assoc; 1973 May; 63(5):199-202. PubMed ID: 4633441
    [No Abstract]   [Full Text] [Related]  

  • 34. Image Gallery: Cutaneous botryomycosis at an unusual site in an immunocompetent patient.
    Razmi T M; Mahajan R; Agrawal P
    Br J Dermatol; 2017 Jan; 176(1):e3. PubMed ID: 28098384
    [No Abstract]   [Full Text] [Related]  

  • 35. A randomized, double-blind phase 2 study comparing the efficacy and safety of an oral fusidic acid loading-dose regimen to oral linezolid for the treatment of acute bacterial skin and skin structure infections.
    Craft JC; Moriarty SR; Clark K; Scott D; Degenhardt TP; Still JG; Corey GR; Das A; Fernandes P
    Clin Infect Dis; 2011 Jun; 52 Suppl 7():S520-6. PubMed ID: 21546629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chronic leg ulcers and Pseudomonas aeruginosa infection].
    Tzika E; Ferrara D; Boehncke WH; Trellu LT; Barouti N
    Rev Med Suisse; 2015 Apr; 11(468):768, 770-2. PubMed ID: 26021138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gram-negative peritonitis in peritoneal dialysis: improved outcome with intraperitoneal ceftazidime.
    Shemin D; Maaz D
    Perit Dial Int; 1996; 16(6):638-41. PubMed ID: 8981536
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacodynamic-based clinical pathway for empiric antibiotic choice in patients with ventilator-associated pneumonia.
    Nicasio AM; Eagye KJ; Nicolau DP; Shore E; Palter M; Pepe J; Kuti JL
    J Crit Care; 2010 Mar; 25(1):69-77. PubMed ID: 19427167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Subcutaneous verrucous lesions in a female renal transplant recipient].
    Eguino P; Aguirrebengoa K; Vilar B; Zarraga S; Ratón JA; Montejo M
    Enferm Infecc Microbiol Clin; 2002 Mar; 20(3):129-30. PubMed ID: 11904087
    [No Abstract]   [Full Text] [Related]  

  • 40. Pooled analysis of single-dose oritavancin in the treatment of acute bacterial skin and skin-structure infections caused by Gram-positive pathogens, including a large patient subset with methicillin-resistant Staphylococcus aureus.
    Corey GR; Arhin FF; Wikler MA; Sahm DF; Kreiswirth BN; Mediavilla JR; Good S; Fiset C; Jiang H; Moeck G; Kabler H; Green S; O'Riordan W;
    Int J Antimicrob Agents; 2016 Nov; 48(5):528-534. PubMed ID: 27665522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.